105 related articles for article (PubMed ID: 23266507)
1. A young girl with refractory intestinal Behçet's disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent.
Watanabe S; Aizawa-Yashiro T; Tsuruga K; Kinjo M; Ito E; Tanaka H
Rheumatol Int; 2013 Dec; 33(12):3105-8. PubMed ID: 23266507
[TBL] [Abstract][Full Text] [Related]
2. Behҫet's Disease, and the Role of TNF-α and TNF-α Blockers.
van der Houwen T; van Laar J
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349254
[TBL] [Abstract][Full Text] [Related]
3. Biological treatments in Behçet's disease: beyond anti-TNF therapy.
Caso F; Costa L; Rigante D; Lucherini OM; Caso P; Bascherini V; Frediani B; Cimaz R; Marrani E; Nieves-Martín L; Atteno M; Raffaele CG; Tarantino G; Galeazzi M; Punzi L; Cantarini L
Mediators Inflamm; 2014; 2014():107421. PubMed ID: 25061259
[TBL] [Abstract][Full Text] [Related]
4. Updated treatment strategies for intestinal Behçet's disease.
Park YE; Cheon JH
Korean J Intern Med; 2018 Jan; 33(1):1-19. PubMed ID: 29207867
[TBL] [Abstract][Full Text] [Related]
5. Outcome predictors for intestinal Behçet's disease.
Park JJ; Kim WH; Cheon JH
Yonsei Med J; 2013 Sep; 54(5):1084-90. PubMed ID: 23918555
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab in the management of Behçet's disease.
Ueda A; Takeno M; Ishigatsubo Y
Ther Clin Risk Manag; 2015; 11():611-9. PubMed ID: 25926738
[TBL] [Abstract][Full Text] [Related]
7. Potential gastrointestinal Behcet's disease flare after treatment with anti-interleukin 17a therapy.
Sun FSK; Chiu NSY; Chung HY
BMC Rheumatol; 2023 Aug; 7(1):25. PubMed ID: 37553722
[TBL] [Abstract][Full Text] [Related]
8. Resuming anti-TNF therapy after development of miliary tuberculosis in Behcet's disease-related uveitis: a case report.
Toriu C; Tsubota K; Usui Y; Goto H
J Ophthalmic Inflamm Infect; 2023 Nov; 13(1):52. PubMed ID: 38017191
[TBL] [Abstract][Full Text] [Related]
9. Young children with Behçet disease have more intestinal involvement.
Hung CH; Lee JH; Chen ST; Yang YH; Lin YT; Wang LC; Yu HH; Chiang BL
J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):225-9. PubMed ID: 23880628
[TBL] [Abstract][Full Text] [Related]
10. Treatment with Biologic Drugs in Pediatric Behçet's Disease: A Comprehensive Analysis of the Published Data.
Batu ED; Sener S; Cam V; Aktay Ayaz N; Ozen S
BioDrugs; 2023 Nov; 37(6):813-828. PubMed ID: 37382804
[TBL] [Abstract][Full Text] [Related]
11. New insights on multigenic autoinflammatory diseases.
Efthimiou P; Petryna O; Nakasato P; Kontzias A
Ther Adv Musculoskelet Dis; 2022; 14():1759720X221117880. PubMed ID: 36081748
[TBL] [Abstract][Full Text] [Related]
12. Informed consent and biological agents in rheumatology and internal medicine.
Mandarelli G; Iannone F; Ferracuti S; Grattagliano I; Benevento M; Solarino B; Ferorelli D; Catanesi R
Eur J Clin Invest; 2022 Sep; 52(9):e13805. PubMed ID: 35488744
[TBL] [Abstract][Full Text] [Related]
13. Clinical Manifestations and Management of Pediatric Behçet's Disease.
Hu YC; Chiang BL; Yang YH
Clin Rev Allergy Immunol; 2021 Oct; 61(2):171-180. PubMed ID: 32767171
[TBL] [Abstract][Full Text] [Related]
14. Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic Agents.
Park Y; Cheon JH
Curr Gastroenterol Rep; 2020 Mar; 22(5):24. PubMed ID: 32193746
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
[TBL] [Abstract][Full Text] [Related]
16. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
Park J; Cheon JH
Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675
[TBL] [Abstract][Full Text] [Related]
17. Update on the Medical Management of Gastrointestinal Behçet's Disease.
Lopalco G; Rigante D; Venerito V; Fabiani C; Franceschini R; Barone M; Lapadula G; Galeazzi M; Frediani B; Iannone F; Cantarini L
Mediators Inflamm; 2017; 2017():1460491. PubMed ID: 28210071
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease.
Kaji M; Kishi T; Miyamae T; Nagata S; Yamanaka H; Fujikawa S
Case Rep Rheumatol; 2015; 2015():716138. PubMed ID: 26609459
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal Behçet's disease: a review.
Skef W; Hamilton MJ; Arayssi T
World J Gastroenterol; 2015 Apr; 21(13):3801-12. PubMed ID: 25852265
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
